These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 26729277)

  • 1. Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes.
    Thomas F; Smith GC; Lu J; Babor R; Booth M; Beban G; Chase JG; Murphy R
    Obes Surg; 2016 Aug; 26(8):1924-31. PubMed ID: 26729277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Changes in Non-esterified Fatty Acids in Patients with Type 2 Diabetes Receiving Bariatric Surgery.
    Nemati R; Lu J; Tura A; Smith G; Murphy R
    Obes Surg; 2017 Mar; 27(3):649-656. PubMed ID: 27530911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.
    Chen Y; Lu J; Nemati R; Plank LD; Murphy R
    Obes Surg; 2019 Nov; 29(11):3605-3621. PubMed ID: 31273649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction.
    Yip S; Signal M; Smith G; Beban G; Booth M; Babor R; Chase JG; Murphy R
    Obes Surg; 2014 Jan; 24(1):62-70. PubMed ID: 23934272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of Vertical sleeve gastrectomy and Roux-en-Y gastric bypass on glucose homeostasis.
    Gudbrandsen OA; Dankel SN; Skumsnes L; Flølo TN; Folkestad OH; Nielsen HJ; Våge V; Mohn AC; Nedrebø BG; Sagen JV; Fernø J; Mellgren G
    Sci Rep; 2019 Oct; 9(1):14817. PubMed ID: 31616017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
    Fatima F; Hjelmesæth J; Birkeland KI; Gulseth HL; Hertel JK; Svanevik M; Sandbu R; Småstuen MC; Hartmann B; Holst JJ; Hofsø D
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e756-e766. PubMed ID: 34463768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal Exclusion but Not Sleeve Gastrectomy Preserves Insulin Secretion, Making It the More Effective Metabolic Procedure.
    Laessle C; Nenova G; Marjanovic G; Seifert G; Kousoulas L; Jaenigen B; Fichtner-Feigl S; Fink JM
    Obes Surg; 2018 May; 28(5):1408-1416. PubMed ID: 29235009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes.
    Steven S; Hollingsworth KG; Small PK; Woodcock SA; Pucci A; Aribasala B; Al-Mrabeh A; Batterham RL; Taylor R
    Diabet Med; 2016 Dec; 33(12):1723-1731. PubMed ID: 27589584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.
    Liaskos C; Koliaki C; Alexiadou K; Argyrakopoulou G; Tentolouris N; Diamantis T; Alexandrou A; Katsilambros N; Kokkinos A
    Obes Surg; 2018 Dec; 28(12):3997-4005. PubMed ID: 30112599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.
    Romero F; Nicolau J; Flores L; Casamitjana R; Ibarzabal A; Lacy A; Vidal J
    Surg Endosc; 2012 Aug; 26(8):2231-9. PubMed ID: 22302537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Achieve Similar Early Improvements in Beta-cell Function in Obese Patients with Type 2 Diabetes.
    Mullally JA; Febres GJ; Bessler M; Korner J
    Sci Rep; 2019 Feb; 9(1):1880. PubMed ID: 30755673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.
    Lee WJ; Ser KH; Chong K; Lee YC; Chen SC; Tsou JJ; Chen JC; Chen CM
    Surgery; 2010 May; 147(5):664-9. PubMed ID: 20004451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes.
    Abbatini F; Rizzello M; Casella G; Alessandri G; Capoccia D; Leonetti F; Basso N
    Surg Endosc; 2010 May; 24(5):1005-10. PubMed ID: 19866235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of type 2 diabetes after Roux-en-Y gastric bypass or sleeve gastrectomy is associated with a distinct glycemic profile.
    Jiménez A; Ceriello A; Casamitjana R; Flores L; Viaplana-Masclans J; Vidal J
    Ann Surg; 2015 Feb; 261(2):316-22. PubMed ID: 25569030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
    Malin SK; Kashyap SR
    Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compared to Sleeve Gastrectomy, Duodenal-Jejunal Bypass with Sleeve Gastrectomy Gives Better Glycemic Control in T2DM Patients, with a Lower β-Cell Response and Similar Appetite Sensations: Mixed-Meal Study.
    Zachariah PJ; Chen CY; Lee WJ; Chen SC; Ser KH; Chen JC; Lee YC
    Obes Surg; 2016 Dec; 26(12):2862-2872. PubMed ID: 27138599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.